Issue link: https://nebusinessmedia.uberflip.com/i/1103856
wbjournal.com | April 15, 2019 | Worcester Business Journal 17 C LLABORATION great care begins with Collaboration WBJ banner ad 9X1.5.indd 1 11/15/2018 4:29:30 PM Top NIH grant winners in Central Mass. Fiscal year 2018 grants, ranked by total funding Top NIH grant winners in Central Mass. Fiscal year 2018 grants, ranked by total funding Grantee Total funding Number of awards Largest project/ funding 1 University of Massachusetts Medical School Worcester $160,982,250 345 University of Massachusetts Center for Clinical and Translational Science $3,523,812 2 Worcester Polytechnic Institute Worcester $4,680,702 13 MR-guided precision conformal ablation therapy for brain tumors * $722,235 3 Embera Neurotherapeutics Inc. Sudbury $3,762,556 1 Novel combination therapy for treatment of cocaine-use disorder $3,762,556 4 Microbiotix Inc. Worcester $3,693,999 10 Oxadiazole inhibitors of non-stop ribosome rescue to treat MDR Neisseria gonorrhoeae $1,114,898 5 Curadel LLC Marlborough $1,732,975 2 Zwitterionic NIR fluorophore for cancer imaging and ureter mapping $989,401 6 Helixbind Inc. Marlborough $1,707,771 3 Diagnostic for neonatal bloodstream infections $996,948 7 Altec Inc. Natick $1,527,237 3 NeuroMAP system for clinical research $793,693 8 Gentuity Inc. Sudbury $1,168,051 1 Micro-imaging catheters for high-resolution, image-guided, endovascular repair of brain aneurysms $1,168,051 9 CG Scientific Worcester $749,990 1 Automated device for high yield mesenchymal stem cell extraction $749,990 10 MatTek Corp. Ashland $703,944 2 Validation of in-vitro human airway model for regulatory toxicity testing $530,965 11 Detectogen Inc. Westborough $665,346 1 Novel, non-invasive antigen detection assay for diagnosis of active visceral leishmaniasis $665,346 12 Clark University Worcester $601,200 2 Determinants of proteolytic degradation of soluble amyloid-beta $375,750 13 Bridge12 Technologies Inc. Framingham $456,951 2 Compact hybrid magnet with high homogeneity for X-Band DNP/NMR and EPR spectroscopy $232,062 14 SignaBlok Inc. Worcester $451,219 2 Development of TREM-1 inhibitors for neovascular retinal diseases $226,223 15 Zata Pharmaceuticals Inc. Worcester $402,225 1 Fluorescently-labeled charge-neutralized oligonucleotides for detection and quantification of microRNAs and oligonucleotide-based therapeutics $402,225 16 GoBlue International LLC Worcester $339,481 1 Digital therapeutic for treatment of generalized anxiety disorder $339,481 17 Bessor Pharma LLC Framingham $299,996 1 Humanized anti-renalase antibodies for unresectable melanoma $299,996 18 Cytosite Biopharma Inc. Sudbury $264,066 1 Clinical translation of diagnostic agent to predict immunotherapy response in solid tumors $264,066 19 Liberating Technologies Inc. Holliston $224,994 1 Voice recognition for improved prosthesis control $224,994 20 Biostage Inc. Holliston $224,615 1 A retrievable auto esophageal implant for long-gap esophageal atresia $224,615 Source: National Institutes of Health, www.nih.gov. Notes: The NIH granted 5,367 awards worth $2.89 billion in funding in Massachusetts in FY 2018; 397 awards worth $185 million were granted in Central Mass. * MR = magnetic resonance - Compiled by: Stephanie R. Meagher, research@nebusinessmedia.com Source: National Institutes of Health, www.nih.gov. Notes: The NIH granted 5,367 awards worth $2.89 billion in funding in Massachusetts in FY 2018; 397 awards worth $185 million were granted in Central Mass. * MR = magnetic resonance - Compiled by: Stephanie R. Meagher, research@nebusinessmedia.com H E A L T H C A R E F O C U S